ClinicalTrials.Veeva

Menu

Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery

U

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Status

Completed

Conditions

Lipoma
Cyst
Nevus
Scar
Seborrheic Keratosis (SK)

Study type

Observational

Funder types

Other

Identifiers

NCT07384299
WuhanUH-2025PFKBaumann

Details and patient eligibility

About

The goal of this observational study is to learn how an individual's skin type influences the wound healing process and scar formation in Chinese patients undergoing facial dermatologic surgery. The main questions it aims to answer are:

How does skin type affect the quality of wound healing after facial surgery?

How does skin type affect the formation of hypertrophic scars after facial surgery?

Researchers will compare groups of patients with different skin types (classified by the Baumann Skin Type) to see if there are significant differences in their healing outcomes and scar characteristics.

Participants in this study will:

Receive standard facial dermatologic surgery as part of their clinical care.

Have their skin type assessed preoperatively.

Undergo scheduled postoperative follow-up assessments at 7 and 90 days to evaluate wound healing and scar development using standardized scales.

Enrollment

173 patients

Sex

All

Ages

14 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged between 14 and 60 years.
  • Clinically and postoperatively pathologically diagnosed with a facial benign tumor (e.g., melanocytic nevus, sebaceous cyst, seborrheic keratosis, etc.) and having undergone standard surgical treatment.
  • Voluntary participation in this study with written informed consent obtained.
  • Commitment to comply with all study protocols and to complete all follow-up visits and data collection procedures.

Exclusion criteria

  • Clinically or postoperatively diagnosed with a facial malignant tumor.
  • Wounds requiring staged excision or planned for secondary intention healing.
  • Surgical site located on or adjacent to the mucosal surface.
  • Known history of allergy to any medications or dressings to be used during or after surgery.
  • Presence of systemic diseases that significantly impair wound healing (e.g., poorly controlled diabetes, immunodeficiency disorders, active infections).
  • Current use of medications affecting wound healing or scar formation (e.g., long-term systemic corticosteroids, immunosuppressants).
  • Pregnancy or lactation.
  • Refusal to provide written informed consent, or anticipated inability to comply with study follow-up and data collection.
  • Concurrent participation in another interventional clinical trial.
  • Any other condition deemed by the investigator as likely to interfere with study results or increase participant risk.

Trial design

173 participants in 2 patient groups

Oily Skin
Description:
classified as having oily skin according to the Baumann questionnaire
Dry Skin
Description:
classified as having dry skin according to the Baumann questionnaire

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems